Topera, Inc., a medical device company that has developed a novel mapping and targeting system for the identification of the sources that sustain complex cardiac arrhythmias, including atrial fibrillation, has completed a $25 million Series C financing round. The round was led by new investor New Enterprise Associates (NEA) with the participation of a new strategic industry partner along with existing investors and the company’s management team. Proceeds will be primarily used to support the planned 2013 commercial launch of the company’s RhythmView™ WorkStation and FIRMap™ Catheter in Europe and the U.S., and to further advance the company’s R&D pipeline and clinical development program. In conjunction with the financing, NEA partner Justin Klein, M.D., has joined the Topera Board of Directors.
Orange County attorneys Dr. Salima Merani and Michael Christensen represented NEA in the IP diligence of Topera.
Read entire article: http://www.nea.com/blog/2013/04/25/topera-medical-the-legend-of-sanjiv-narayan/